Popular blood pressure drug recalled in the U.S. for cancer-causing impurity

Popular blood pressure drug recalled in the U.S. for cancer-causing impurity

A U.S. unit of Indian generic drugmaker Aurobindo Pharma Ltd will recall 80 lots of medicines containing blood pressure drug valsartan that were found

Health Canada continues investigation as more heartburn medications recalled
Ruth Bader Ginsburg says she is on her way to ‘being very well’ after cancer treatment
Woman with cancer awarded $29M in Johnson and Johnson talcum powder suit

A U.S. unit of Indian generic drugmaker Aurobindo Pharma Ltd will recall 80 lots of medicines containing blood pressure drug valsartan that were found to have a probable cancer-causing impurity, according to the U.S. Food and Drug Administration.Story continues belowThe impurity N-Nitrosodiethylamine (NDEA) was detected in quantities above the acceptable limit in certain tablets containing valsartan, the FDA said.READ MORE: High blood pressure is a ‘silent killer’ — but many still don’t know the risksThe announcement comes a month after Mylan NV said it will recall all lots of its blood pressure medicines containing valsartan, an angiotensin II receptor blocker, after global health authorities clamped down on the drug.No drugs in Canadian market are affected by the Aurobindo Pharma recall, a Health Canada spokesperson told Global News.WATCH BELOW: Several blood pressure medications recalled in 2018Health Canada finds second carcinogen in recalled medication

COMMENTS

WORDPRESS: 0
DISQUS: 0